arrow
C

Caren Sourij

Medical University of Graz
H指数:13
被引数:639

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Safety and efficacy of intermittent fasting with or without exercise in people living with overweight or obesity and type 2 diabetes—The INTERFAST-3 study design

间歇性禁食联合或不联合运动对超重或肥胖合并2型糖尿病人群的安全性与有效性——INTERFAST-3研究设计

2026-04-150
OAAI
Decision accuracy of simultaneously used real-time CGM versus intermittently scanned CGM around exercise in type 1 diabetes: A secondary analysis of the ULTRAFLEXI-1 study

运动期间同时使用实时CGM与间歇扫描CGM的决策准确性:ULTRAFLEXI-1研究的二次分析

2026-02-010
PRE
Impact of intermittent fasting on self-regulatory behaviour and sleep in participants with insulin-treated type 2 diabetes: A secondary analysis of the INTERFAST-2 randomised controlled trial

间歇性禁食对使用胰岛素治疗的2型糖尿病患者自我调节行为和睡眠的影响:INTERFAST-2随机对照试验的二次分析

2026-01-120
OAAI
Acute and prolonged effects of aerobic endurance training on N-lactoyl-phenylalanine and inflammatory markers in individuals with type 1 diabetes: An exploratory analysis of the ULTRAFLEXI-1 study

有氧耐力训练对1型糖尿病个体N-乳酰苯丙氨酸和炎症标志物的急性与长期影响:ULTRAFLEXI-1研究的探索性分析

2025-10-290
OAAI
Metabolic risk factor targets in relation to clinical characteristics and comorbidities among individuals with type 2 diabetes treated in primary care - The countrywide cross-sectional AUSTRO-PROFIT study

在接受初级保健治疗的2型糖尿病患者中,代谢危险因素目标与临床特征和合并症的关系-全国横断面astr-pro利研究

2024-10-030
OAAI
Comparison of Insulin Glargine 300 U/mL and Insulin Degludec 100 U/mL Around Spontaneous Exercise Sessions in Adults with Type 1 Diabetes: A Randomized Cross-Over Trial (ULTRAFLEXI-1 Study)

成人1型糖尿病患者自发运动前后甘精胰岛素300 U/mL和胰岛素德谷100 U/mL的比较: 一项随机交叉试验 (ULTRAFLEXI-1研究)

2023-03-017
PRE
Glucose Metabolism and Metabolomic Changes in Response to Prolonged Fasting in Individuals with Obesity, Type 2 Diabetes and Non-Obese People-A Cohort Trial
2023-01-184
OAAI
Only Subclinical Alterations in the Haemostatic System of People with Diabetes after COVID-19 Vaccination
2022-12-201
OAAI
Severe acute respiratory syndrome coronavirus 2 spike antibody level decline is more pronounced after the second vaccination, but response to the third vaccination is similar in people with type 1 and type 2 diabetes compared with healthy controls: The prospective COVAC-DM cohort study
2022-09-153
OAAI
Biomarkers Predictive for In-Hospital Mortality in Patients with Diabetes Mellitus and Prediabetes Hospitalized for COVID-19 in Austria: An Analysis of COVID-19 in Diabetes Registry
2022-06-134
OAAI
A Comparison of Insulin Glargine U300 and Insulin Degludec around Spontaneous Exercise Sessions in People with Type 1 Diabetes-The ULTRAFLEXI-1 Study
2022-06-010
PRE